Pharmafile Logo
Pharmafocus logo
Advanced Search

GCI bags Novartis’ social media director

November 8, 2010
Medical Communications GCI Health, Mark Davis, Novartis, appointment, medical communications

Novartis Pharmaceuticals’ former social media director Mark Davis has moved to GCI Health. He has been appointed to lead the …

Appointment

NICE ‘surprised’ at downgrading of its role

November 5, 2010
Sales and Marketing Andrew Dillon, GP prescribing deicisions, NICE, QALY, incremental cost-effectiveness ratio, value-based pricing

NICE received no warning that its health technology assessment role is to be downgraded, the watchdog’s head has admitted. In …

News

Roche’s melanoma candidate impresses in phase II trials

November 5, 2010
Research and Development BRAF protein, Cancer, Phase II, Plexxikon, RG7204, Roche

Roche’s mid-stage melanoma candidate has produced positive results in a difficult to treat cancer. RG7204 is an investigational, first-in-class molecule …

News

Digital health and the Social Network

November 5, 2010
Medical Communications Facebook, Red Door, The Social Network, digital pharma, social media

Followers of film will be only too aware that we are about to embark on ‘Oscar season’. Cinematic features are …

Feature
Bayer's Levitra

Bayer faces ABPI audit after “shocking” Levitra error

November 5, 2010
Medical Communications, Sales and Marketing ABPI, ABPI Code of Practice, Bayer, PMCPA

Bayer has been accused of a “shocking error of judgement” after promotional material for its erectile dysfunction brand Levitra (vardenafil) …

News

Danielle James and Kate Morrison join Virgo

November 5, 2010
Medical Communications Danielle James, Kate Morrison, Virgo, Virgo Health PR, appointment, medical communications

Virgo Health has expanded its medical education and ethical health teams with two new appointments. Danielle James (pictured) has been …

Appointment

Don’t replace NICE with another ‘misguided experiment’

November 5, 2010
Sales and Marketing NHS, NICE, Stockholm Network, medicines access, risk-sharing

Replacing NICE with a similar system would be detrimental to UK healthcare, according to the Stockholm Network, which further warns …

News

Another US heparin recall for OSCS contamination

November 5, 2010
Manufacturing and Production API, B. Braun Medical, heparin, manufacturing compliance, recalls

US pharmaceutical company B.

News

NicOx to halve HQ workforce

November 4, 2010
Research and Development, Sales and Marketing NicOx, job cuts, naproxcinod, pharma jobs

French pharmaceutical company NicOx is to halve the workforce at its Sophia Antipolis headquarters and is considering restructuring its Italian …

News
Woolley_Pau_Yvette

Senior creative promotions at Woolley Pau

November 4, 2010
Medical Communications Eric Houseknecht, Woolley Pau, Yvette Cumbers, appointment, medical communications

Woolley Pau has promoted senior copywriter Yvette Cumbers and senior art director Eric Houseknecht to the level of deputy creative …

Appointment

Doctors.net.uk boosts business development team

November 4, 2010
Sales and Marketing Doctors.net.uk, Jo Bell, Lizzie Evans, Paul Kelly, Phil Oldroyd, appointment, sales and marketing

Online healthcare professional network Doctors.net.uk has made three business development appointments and added a new project manager to its team. …

Appointment

CME Spotlight: Making European CME work

November 4, 2010
Medical Communications CME, CME Spotlight, Continuing medical education, Eugene Pozniak

Since spring I have been dealing with a team of builders who have missed every deadline possible, to the extent …

Feature

Biogen set to axe 650 jobs and focus on neurology

November 4, 2010
Research and Development, Sales and Marketing Biogen, Rituxan, job cuts, pharma jobs

Biogen Idec is set to cut hundreds of jobs and refocus its R&D in an effort to cut costs by …

News
ABPI Code of Practice

UK pharma to declare doctor payments

November 4, 2010
Medical Communications, Sales and Marketing ABPI, ABPI Code of Practice, advisory boards, healthcare professionals, pharma industry standards

Pharma companies in the UK have agreed to restrict their promotional giveaways and to declare payments to doctors. Another common …

News

New Commercial Realities

November 4, 2010
Sales and Marketing Kinapse, White paper

Faced with a changing healthcare environment and the prospect of diminishing commercial returns, pharmaceutical companies must undertake a fundamental and …

Feature
White paper
Blog footer

Digital Pharma: Diabetes patients and Facebook

November 3, 2010
Medical Communications Digital Pharma blog, Facebook, diabetes, patient information, social networking

A quarter of comments on the 15 largest Facebook communities for diabetes patients are promotional – generally for non-FDA approved …

News

Medivir appoints Charlotte Edenius

November 3, 2010
Research and Development Charlotte Edenius, Medivir, appointment, research and development

Swedish specialty pharmaceutical company Medivir has appointed Charlotte Edenius to the newly created position of VP of research and development …

Appointment

The utility of next generation sequencing in drug development

November 3, 2010
Research and Development Dr Cheng Eng Ang, Illumina, Source BioScience, drug development, genomics, human genome, next generation sequencing

Drug development studies are extremely expensive, costing many millions of pounds and taking up to 12 years to bring a …

Feature
Advanced melanoma

BMS skin cancer drug hits US regulatory delay

November 3, 2010
Research and Development BMS, Bristol-Myers Squibb, FDA, MDX010-020 trial, ipilimumab, skin cancer

US regulators have announced they need more time to assess Bristol-Myers Squibb’s skin cancer treatment ipilimumab. The FDA will not …

News

Lundbeck issues Lexapro patent warning

November 3, 2010
Sales and Marketing Azilect, Cipralex, Forest Laboratories, Lexapro, Lundbeck, Xenazine

Neurological disorder specialist Lundbeck has posted a modest growth in revenue for the third quarter, but warned the looming patent …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026